Back to funds
View filing
SILVERARC CAPITAL MANAGEMENT, LLC
hedge fundUpdated 28 days agoManaged by Silverarc Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$962.2M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
93.4%
Weight of largest holdings
Annualized return
48.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $242.3M |
| Q2 2023 | $323.3M |
| Q3 2023 | $329.8M |
| Q4 2023 | $336M |
| Q1 2024 | $360.1M |
| Q2 2024 | $423.9M |
| Q3 2024 | $445.3M |
| Q4 2024 | $457.2M |
| Q1 2025 | $489M |
| Q2 2025 | $542.3M |
| Q3 2025 | $741.6M |
| Q4 2025 | $720.1M |
| Q1 2026 | $979.8M |
| Q2 2026 | $962.2M |
Top holdings
73 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ASND ASCENDIS PHARMA A/S | $55M | 206.2K | 5.72% | — |
| 2 | C CELC CELCUITY INC | $52.4M | 501.0K | 5.45% | — |
| 3 | C COGT COGENT BIOSCIENCES INC | $49.6M | 1.28M | 5.15% | — |
| 4 | U URGN UROGEN PHARMA LTD | $47.9M | 1.30M | 4.98% | — |
| 5 | I IMNM IMMUNOME INC | $42.7M | 2.02M | 4.44% | — |
| 6 | D DNTH DIANTHUS THERAPEUTICS INC | $38M | 390.0K | 3.95% | — |
| 7 | R RYTM RHYTHM PHARMACEUTICALS INC | $34.6M | 311.5K | 3.59% | — |
| 8 | O ORKA ORUKA THERAPEUTICS INC | $33.6M | 352.8K | 3.49% | — |
| 9 | M MNST MONTE ROSA THERAPEUTICS INC | $26.8M | 1.11M | 2.79% | — |
| 10 | S SNDX SYNDAX PHARMACEUTICALS INC | $26.5M | 1.21M | 2.76% | — |
| 11 | E ELVN ENLIVEN THERAPEUTICS INC | $24.8M | 489.4K | 2.58% | — |
| 12 | I IMVT IMMUNOVANT INC | $23.9M | 619.1K | 2.48% | — |
| 13 | E EQR ERASCA INC | $23.1M | 1.26M | 2.40% | — |
| 14 | S SGMT SAGIMET BIOSCIENCES INC | $22.6M | 2.93M | 2.35% | — |
| 15 | A AAVXF ABIVAX SA | $22.6M | 169.6K | 2.35% | — |
| 16 | P PRAX PRAXIS PRECISION MEDICINES I | $22M | 65.7K | 2.29% | — |
| 17 | K KOD KODIAK SCIENCES INC | $21.3M | 546.3K | 2.21% | — |
| 18 | ? N/A ARK ETF TR | $21M | 500.0K | 2.19% | — |
| 19 | D DFTX DEFINIUM THERAPEUTICS INC | $18.8M | 400.0K | 1.96% | — |
| 20 | V VCYT VERACYTE INC | $18.7M | 318.0K | 1.94% | — |